The continued advancement in the field of antibody based therapies is dependent on the successful discovery and development of novel therapeutic antibody candidates. This requires powerful tools that can deliver rapid, actionable insights to fully understand the ability of candidate antibodies to interrupt the cellular and molecular processes leading to disease states.
Download this white paper to learn how scientists are using suspension-cell assay formats and encoding technology to develop powerful high content screens for their antibody libraries using the Intellicyt iQue® Screener PLUS platform.
To read the white paper you will be asked to fill out a very brief registration form and those details will be used by the ‘sponsor’s’ own internal marketing and sales department.
Sponsored by intellicyt